CHINA PHARMA HOLDINGS, INC. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
China Pharma Holdings, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • China Pharma Holdings, Inc. Return On Equity for the quarter ending September 30, 2024 was -63.9 %, a 0.2% increase year-over-year.
  • China Pharma Holdings, Inc. annual Return On Equity for 2023 was -54.5 %, a 43.4% increase from 2022.
  • China Pharma Holdings, Inc. annual Return On Equity for 2022 was -96.4 %, a 88.3% decline from 2021.
  • China Pharma Holdings, Inc. annual Return On Equity for 2021 was -51.2 %, a 45.7% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -54.5 +41.9 +43.4% Jan 1, 2023 Dec 31, 2023
2022 -96.4 -45.2 -88.3% Jan 1, 2022 Dec 31, 2022
2021 -51.2 -16.1 -45.7% Jan 1, 2021 Dec 31, 2021
2020 -35.1 +51 +59.2% Jan 1, 2020 Dec 31, 2020
2019 -86.1 -58.1 -207% Jan 1, 2019 Dec 31, 2019
2018 -28.1 +7.71 +21.6% Jan 1, 2018 Dec 31, 2018
2017 -35.8 -21.8 -155% Jan 1, 2017 Dec 31, 2017
2016 -14 +4.77 +25.4% Jan 1, 2016 Dec 31, 2016
2015 -18.8 +15.8 +45.7% Jan 1, 2015 Dec 31, 2015
2014 -34.6 -20.4 -145% Jan 1, 2014 Dec 31, 2014
2013 -14.1 -17.2 -553% Jan 1, 2013 Dec 31, 2013
2012 3.12 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.